Cody Staats, MS

Cody
Staats
MS
Program Manager - RePORT Brazil

Cody is a Program Manager for the Vanderbilt Tuberculosis Center working on RePORT – Brazil.  Before joining VUMC, he worked for Arizona State University's Center for Science and the Imagination. His experience includes nearly a decade of program and grant management overseeing pre-award, post-award, and closeout for gifts/grants from diverse funding sources including the National Science Foundation, National Institutes of Health, USAID, NASA, CDC, Intel, Google, the World Bank, and more.

In 2014 he graduated with a Bachelor of Science in Economics from Arizona State University, which was followed by a Master of Science in Global Technology and Development from the same institution in 2019. Cody won a USAID graduate development research award in 2018 to conduct research on sustainable water futures in the Cantareira watershed of São Paulo, Brazil. He is fluent in Brazilian Portuguese.

cody.staats@vumc.org

VTC hosts visitors from Brazil, South Africa, UW for grant project meeting

June 14, 2022
Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our LTBI R01 project “Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts” (NIH R01AI147765). The event, which took place between May 31st and June 2nd, included presentations about ongoing research and initial data, working group sessions, and breakout meetings.

January 2022 DAIDS Council-Approved Concepts

Notice of Special Interest (NOSI)—Identifying Immune Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection Notice of Special Interest—proposed FY 2023 initiative Contact: Josh Radke josh.radke@nih.gov

Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed), due 06/08/2022

Open Date (Earliest Submission Date): May 08, 2022 Expiration Date: June 09, 2022 The purpose of this Funding Opportunity Announcement (FOA) is to advance research to discover and validate novel biomarkers of Tuberculosis (TB) infection and subsequent risk of progression to TB disease in young children with and without HIV. https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-015.html

Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed), due 07/08/2022

Open Date (Earliest Submission Date): June 08, 2022 Expiration Date: July 09, 2022 The purpose of this Funding Opportunity Announcement (FOA) is to support the development of new diagnostic technologies for tuberculosis (TB) drug susceptibility testing (DST), including point of care (POC) DST and companion diagnostics for new TB drugs. https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-016.html

Contract Solicitation - 2022 NIAID Omnibus Broad Agency Announcement

NIAID 2022 OMNIBUS BROAD AGENCY ANNOUNCEMENT (BAA) NO. HHS-NIH-NIAID-BAA2022-1 contains four (4) distinct Research Areas, each with specified closing date and time.   The proposal due date of March 18, 2022, specified in this solicitation posting, is the due date for Research Area 003 only.  An Amendment will be issued at a later date to update the proposal due date for responses to Research Areas 001, 002, 004.  The proposal due dates for each Research Area are identified below:
NIH
RSS: